Accurate screening for insulin resistance in PCOS women using fasting insulin concentrations

References

• Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745–9
   PubMed Web of Science ®Google Scholar
• Rotterdam E. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod (Oxford, England) 2004;19:41–7
   PubMed Web of Science ®Google Scholar
• Dokras A, Bochner M, Hollinrake E, et al. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005;106:131–7
   PubMed Web of Science ®Google Scholar
• DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Gastroint Liver Physiol 1979;237:214–23
   PubMed Web of Science ®Google Scholar
• Bergman RN, Ider YZ, Bowden CR, et al. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667–77
   PubMed Web of Science ®Google Scholar
• Hosker J, Matthews DR, Rudenski AS, et al. Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man. Diabetologia 1985;28:401–11
   PubMed Web of Science ®Google Scholar
• Salley KES, Wickman EP, Cheang KI, et al. Position statement: glucose intolerance in polycystic ovary syndrome – a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92:4546–56
   PubMed Web of Science ®Google Scholar
• Mattle V, Kraus-Kinsky E, Schulze E, et al. Heterozygote adrenale Enzymdefekte mit Hyperandrogenämie. J Reprod Endokrinol 2006;3:319–23
   Google Scholar
• Lejeune-Lenain C, Chantraine F, Dufrasnes M, et al. An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia. Clin Endocrinol 1980;12:525–35
   Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97
   PubMed Web of Science ®Google Scholar
• WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia – Report of a WHO/IDF Consultation. Joint WHO and IDF Technical Advisory Group Meeting, Geneva; 2006, ISBN: 978 92 4 159493 6
   Google Scholar
• Ciampelli M, Leoni F, Cucinelli F, et al. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J Clin Endocrinol Metab 2005;90:1398–406
   PubMed Web of Science ®Google Scholar
• Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1990;10:167–75
   PubMed Web of Science ®Google Scholar
• Hadžiomerović D, Rabenbauer B, Wildt L. Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women. Fertil Steril 2006;86:651–7
   PubMedGoogle Scholar
• Deugarte C, Bartolucci A, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83:1454–60
   PubMed Web of Science ®Google Scholar
• Coviello A, Legro R, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006;91:492–7
   PubMed Web of Science ®Google Scholar
• Shroff R, Syrop CH, Davis W, et al. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 2007;88:1389–95
   PubMed Web of Science ®Google Scholar
• Carmina E, Legro RS, Stamets K, et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Human Reprod 2003;18:2289–93
   PubMed Web of Science ®Google Scholar
• Kauffman R, Baker VM, DiMarino P, et al. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002;187:1362–9
   PubMed Web of Science ®Google Scholar
• Radikova Z, Koska J, Huckova M, et al. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes 2006;114:249–56
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402–10
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo R. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004;82:661–5
   PubMed Web of Science ®Google Scholar
• Legro R, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694–8
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–70
   PubMed Web of Science ®Google Scholar
• Stumvoll M, Mitrakou A, Pirmenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295–301
   PubMed Web of Science ®Google Scholar